SmartCells, a key member of the FamiCord Group, has elevated the benchmark for stem cell banking in the UAE by securing AABB accreditation, demonstrating unwavering dedication to the highest standards of quality and patient safety.
This achievement reinforces the group’s commitment to providing world-class stem cell storage and regenerative medicine services across the globe – now including the rapidly growing Middle East market.
The AABB (Association for the Advancement of Blood & Biotherapies) is globally recognized as the gold standard in blood and cellular therapy accreditation. Earning this distinction confirms SmartCells’ compliance with the most rigorous international standards in processing, storing, and managing stem cells.
Strategic Expansion into the UAE via DHCC
This milestone follows FamiCord Group’s strategic investment in the Middle East, marked by the launch of a state-of-the-art laboratory in Dubai Healthcare City (DHCC) – the UAE’s premier healthcare free zone. Operating within DHCC ensures that SmartCells aligns with the highest regulatory and ethical standards, while being embedded in a vibrant and trusted medical ecosystem.
FamiCord Group is the number one stem cell banking network in Europe and the third largest worldwide, with operations in over 35 countries and more than 1,000,000 stored samples. The group holds multiple global accreditations, including AABB and FACT, and its expansion into the UAE represents a long-term commitment to raising the standards of stem cell services in the region.
“Achieving AABB accreditation in the UAE is a proud moment for us and a testament to our ongoing commitment to quality and trust,” said Dr. Hadeel Alkhzai, Country Manager for SmartCells UAE. “Our facility in DHCC allows us to operate at the heart of the region’s healthcare ecosystem while delivering services that meet international benchmarks.”
“This accreditation confirms that our medical and laboratory protocols are of the highest global standard,” added Dr. Marwa Abdelhalim, Medical Director at SmartCells UAE. “It ensures that families and healthcare providers can place their full confidence in the integrity and safety of our services.”
Comprehensive stem cell services backed by international standards
With the UAE emerging as a leading healthcare hub, SmartCells’ AABB accreditation and presence within Dubai Healthcare City reinforce its commitment to delivering internationally recognized standards in stem cell banking.
SmartCells provides end-to-end services including the collection, processing, and secure long-term storage of cord blood and cord tissue. These services offer families access to potential future therapies for a wide range of blood, immune, and genetic disorders.
To date, the FamiCord Group has supplied stem cells for clinical use in more than 7,000 patients worldwide. These therapies have supported treatment across multiple fields, including haematology, neurology, ophthalmology, orthopaedics, and dermatology – highlighting the expanding impact of stem cell therapies in modern medicine.
For more information about SmartCells and its AABB-accredited lab in DHCC, Dubai, visit www.smartcells.ae.
